Research
Hormonal
Medication adherence increased from 52.8% to 84%.
Encouraging medication adherence can significantly improve patient outcomes.
StrongSupportsmedium confidence
Medication adherence increased from 52.8% to 84%.
Why this rating
Based on the structured follow-up program and the significant results.
Source
The impact of the Mediterranean diet and close monitoring on glycemic control and weight management in poorly controlled type 2 diabetes
Mehmet Erbakan et al. · Mediterranean Journal of Nutrition and Metabolism · 2025
DOI 10.1177/1973798x251349603
cohort · n=127
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →